Radius Health Inc (NASDAQ: RDUS) Rating Reiterated at Jefferies Group

Radius Health Inc (NASDAQ: RDUS) had its Hold rating reiterated by equities researchers at Jefferies Group in a research note to investors. With a rating of Hold on the shares, Radius Health Inc has a 52-week high of $77.10. The one-year price target of $56.88 is higher than the opening price of $55.63, causing a number of other analysts to issue statements on the company in recent days. Usually, after analysts assign a “reiterated rating” report on a stock, they will subsequently issue other updates, usually followed by a price target change.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Shares of Radius Health Inc (NASDAQ: RDUS) opened at $55.63 yesterday trading between $55.27 and $57.20, and last traded at $56.73, which represents an increase of $1.62 over the previous closing price.

Radius Health Inc (NASDAQ: RDUS) now has a market cap of 2.44B.

The stock’s average daily volume is 929,830 shares out of a total float 31,454,000 and some 1,093,675 shares crossed the trading desk yesterday, 9 percent above normal. Substantial increases in trading volume and price appreciation together could mean heavy volume accumulation by institutional investors.

While increased trading for short periods will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks expresses a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

By tracking the activity of these professional investors and how they affect moving averages,it allows for traders to make more impactful decisions on trades.

With that in mind, Radius Health Inc (NASDAQ: RDUS) now has a 50-day MA of $54.72 and 200-day MA of $40.96. It has traded in a 52-week range between $24.75 – 77.10 and today’s last price is 0.26% lower than the 52 week high of $77.10.

Earnings growth is an important factor to consider when investing in stocks and investors seek companies that have been successful at growing their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.